Study sites in Phoenix, Arizona, Houston, Texas, and Chicago, Illinois have started screening for the study. Remaining study sites in the following cities will begin screening later this year and into early 2020
https://www.rettsyndrome.org/acadia-announces-launch-of-phase-3-lavender-study-for-trofinetide
Phase 3 initiated, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
-0.310(1.54%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.74 | $4.663M | 234.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | $19.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.89 | 765 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |